News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
854,167 Results
Type
Article (86983)
Company Profile (704)
Press Release (766479)
Multimedia
Podcasts (152)
Webinars (19)
Section
Business (232870)
Career Advice (4133)
Deals (39768)
Drug Delivery (130)
Drug Development (91134)
Employer Resources (199)
FDA (18208)
Job Trends (17372)
News (396952)
Policy (39839)
Tag
Academia (3002)
Academic (2)
Accelerated approval (14)
Adcomms (33)
Allergies (109)
Alliances (56977)
ALS (123)
Alzheimer's disease (1614)
Antibody-drug conjugate (ADC) (192)
Approvals (18163)
Artificial intelligence (409)
Autoimmune disease (39)
Automation (20)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (139)
Biotechnology (482)
Bladder cancer (103)
Brain cancer (41)
Breast cancer (408)
Cancer (3205)
Cardiovascular disease (258)
Career advice (3542)
Career pathing (34)
CAR-T (214)
CDC (43)
Cell therapy (590)
Cervical cancer (25)
Clinical research (74485)
Collaboration (1155)
Company closure (3)
Compensation (733)
Complete response letters (38)
COVID-19 (2915)
CRISPR (70)
C-suite (389)
Cystic fibrosis (124)
Data (3258)
Decentralized trials (2)
Denatured (54)
Depression (83)
Diabetes (384)
Diagnostics (6995)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (193)
Drug pricing (156)
Drug shortages (36)
Duchenne muscular dystrophy (160)
Earnings (97828)
Editorial (50)
Employer branding (25)
Employer resources (169)
Events (131628)
Executive appointments (925)
FDA (20083)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1039)
Gene editing (152)
Generative AI (42)
Gene therapy (463)
GLP-1 (946)
Government (5285)
Grass and pollen (7)
Guidances (221)
Healthcare (20920)
HIV (46)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (194)
Immuno-oncology (13)
Indications (42)
Infectious disease (3120)
Inflammatory bowel disease (167)
Inflation Reduction Act (13)
Influenza (78)
Intellectual property (130)
Interviews (813)
IPO (17907)
IRA (57)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (60)
Layoffs (602)
Leadership (27)
Legal (10138)
Liver cancer (85)
Longevity (12)
Lung cancer (449)
Lymphoma (224)
Machine learning (13)
Management (65)
Manufacturing (478)
MASH (104)
Medical device (14750)
Medtech (14756)
Mergers & acquisitions (22609)
Metabolic disorders (978)
Multiple sclerosis (107)
NASH (23)
Neurodegenerative disease (165)
Neuropsychiatric disorders (47)
Neuroscience (2409)
NextGen: Class of 2025 (7687)
Non-profit (5091)
Now hiring (51)
Obesity (497)
Opinion (292)
Ovarian cancer (107)
Pain (128)
Pancreatic cancer (133)
Parkinson's disease (204)
Partnered (25)
Patents (339)
Patient recruitment (187)
Peanut (55)
People (65796)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (22977)
Phase II (32342)
Phase III (24361)
Pipeline (1787)
Policy (252)
Postmarket research (3554)
Preclinical (10380)
Press Release (72)
Prostate cancer (156)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (544)
Real estate (7402)
Recruiting (76)
Regulatory (27321)
Reports (62)
Research institute (2667)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (12)
RSV (61)
Schizophrenia (104)
Series A (174)
Series B (120)
Service/supplier (30)
Sickle cell disease (69)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (37)
Startups (4307)
State (2)
Stomach cancer (17)
Supply chain (86)
Tariffs (71)
The Weekly (96)
Vaccines (938)
Venture capital (60)
Weight loss (334)
Women's health (52)
Worklife (20)
Date
Today (108)
Last 7 days (572)
Last 30 days (1990)
Last 365 days (33897)
2025 (19706)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1277)
Alabama (72)
Alaska (7)
Arizona (281)
Arkansas (14)
Asia (50597)
Australia (8892)
California (8022)
Canada (2487)
China (742)
Colorado (342)
Connecticut (357)
Delaware (215)
Europe (116132)
Florida (1198)
Georgia (274)
Hawaii (3)
Idaho (67)
Illinois (759)
India (34)
Indiana (396)
Iowa (19)
Japan (248)
Kansas (117)
Kentucky (34)
Louisiana (19)
Maine (73)
Maryland (1133)
Massachusetts (6142)
Michigan (280)
Minnesota (501)
Mississippi (4)
Missouri (107)
Montana (32)
Nebraska (26)
Nevada (87)
New Hampshire (74)
New Jersey (2252)
New Mexico (31)
New York (2236)
North Carolina (1267)
North Dakota (10)
Northern California (3483)
Ohio (259)
Oklahoma (17)
Oregon (48)
Pennsylvania (1718)
Puerto Rico (18)
Rhode Island (40)
South America (1654)
South Carolina (36)
South Dakota (1)
Southern California (2985)
Tennessee (132)
Texas (1242)
United States (30261)
Utah (233)
Virginia (221)
Washington D.C. (80)
Washington State (705)
West Virginia (4)
Wisconsin (87)
There are 854,167 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
‘Very Impressive’ Amvuttra ATTR-CM Sales Send Alnylam Soaring
In its first commercial quarter for ATTR-cardiomyopathy, Alnylam’s Amvuttra reached roughly 1,400 patients and made more than $490 million.
August 1, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Moderna Reports Second Quarter 2025 Financial Results and Provides Business Updates
August 1, 2025
·
16 min read
Layoffs
Merck’s $3B Savings Push Claims 6,000 Jobs
Merck has characterized its cost-cutting initiative as more of a reallocation of resources to support other, higher-growth areas of its business.
August 1, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Medicenna Therapeutics Reports First Quarter Fiscal 2026 Financial Results and Operational Highlights
August 1, 2025
·
9 min read
Press Releases
Regeneron Reports Second Quarter 2025 Financial and Operating Results
August 1, 2025
·
30 min read
Press Releases
ANI Pharmaceuticals to Discuss Second Quarter 2025 Financial Results on August 8, 2025, at 8:30 a.m. ET
August 1, 2025
·
1 min read
Press Releases
BrightSpring Health Services, Inc. Reports Second Quarter 2025 Financial Results and Increases Full Year 2025 Guidance
August 1, 2025
·
25 min read
Press Releases
Energenesis Biomedical Announces Positive Phase I Results for ENERGI-F705PD, a Potential Disease-Modifying Treatment for Parkinson’s Disease
August 1, 2025
·
4 min read
Press Releases
Oculis Upsized Loan Facility to Access up to CHF 100 million
August 1, 2025
·
4 min read
Press Releases
Following the Filing for the Opening of Reorganization Proceedings, Poxel Announces Changes to Its Corporate Governance
August 1, 2025
·
6 min read
1 of 85,417
Next
